vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $18.9M, roughly 1.2× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs 14.6%, a 0.0% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -23.9%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
ELMD vs GENC — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $23.6M |
| Net Profit | $2.8M | $3.4M |
| Gross Margin | 78.4% | 28.7% |
| Operating Margin | 19.2% | 13.2% |
| Net Margin | 14.6% | 14.6% |
| Revenue YoY | 16.3% | -25.0% |
| Net Profit YoY | 40.3% | -9.8% |
| EPS (diluted) | $0.32 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $23.6M | ||
| Q3 25 | $16.9M | $18.8M | ||
| Q2 25 | $17.4M | $27.0M | ||
| Q1 25 | $15.7M | $38.2M | ||
| Q4 24 | $16.3M | $31.4M | ||
| Q3 24 | $14.7M | $20.9M | ||
| Q2 24 | $14.8M | $25.6M | ||
| Q1 24 | $13.9M | $40.7M |
| Q4 25 | $2.8M | $3.4M | ||
| Q3 25 | $2.1M | $1.9M | ||
| Q2 25 | $2.2M | $3.8M | ||
| Q1 25 | $1.9M | $6.1M | ||
| Q4 24 | $2.0M | $3.8M | ||
| Q3 24 | $1.5M | $1.5M | ||
| Q2 24 | $1.8M | $2.6M | ||
| Q1 24 | $1.5M | $6.2M |
| Q4 25 | 78.4% | 28.7% | ||
| Q3 25 | 78.1% | 24.2% | ||
| Q2 25 | 78.3% | 26.5% | ||
| Q1 25 | 78.0% | 29.7% | ||
| Q4 24 | 77.7% | 27.6% | ||
| Q3 24 | 78.3% | 25.6% | ||
| Q2 24 | 76.2% | 23.9% | ||
| Q1 24 | 74.8% | 30.3% |
| Q4 25 | 19.2% | 13.2% | ||
| Q3 25 | 15.8% | -1.2% | ||
| Q2 25 | 17.5% | 11.6% | ||
| Q1 25 | 13.6% | 17.0% | ||
| Q4 24 | 15.6% | 14.7% | ||
| Q3 24 | 13.2% | 5.9% | ||
| Q2 24 | 15.7% | 7.8% | ||
| Q1 24 | 13.3% | 17.4% |
| Q4 25 | 14.6% | 14.6% | ||
| Q3 25 | 12.6% | 10.2% | ||
| Q2 25 | 12.7% | 14.2% | ||
| Q1 25 | 12.1% | 16.0% | ||
| Q4 24 | 12.1% | 12.1% | ||
| Q3 24 | 10.0% | 6.9% | ||
| Q2 24 | 12.3% | 10.0% | ||
| Q1 24 | 10.8% | 15.3% |
| Q4 25 | $0.32 | $0.23 | ||
| Q3 25 | $0.25 | $0.13 | ||
| Q2 25 | $0.26 | $0.26 | ||
| Q1 25 | $0.21 | $0.42 | ||
| Q4 24 | $0.22 | $0.26 | ||
| Q3 24 | $0.16 | $0.10 | ||
| Q2 24 | $0.20 | $0.17 | ||
| Q1 24 | $0.17 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $147.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $215.2M |
| Total Assets | $54.9M | $228.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $147.7M | ||
| Q3 25 | $14.1M | $136.3M | ||
| Q2 25 | $15.3M | $136.0M | ||
| Q1 25 | $15.2M | $143.7M | ||
| Q4 24 | $16.2M | $130.1M | ||
| Q3 24 | $13.9M | $115.4M | ||
| Q2 24 | $16.1M | $116.6M | ||
| Q1 24 | $11.7M | $117.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $45.4M | $215.2M | ||
| Q3 25 | $44.7M | $211.8M | ||
| Q2 25 | $43.2M | $209.9M | ||
| Q1 25 | $43.9M | $206.1M | ||
| Q4 24 | $43.6M | $200.0M | ||
| Q3 24 | $41.5M | $196.1M | ||
| Q2 24 | $44.5M | $194.7M | ||
| Q1 24 | $42.5M | $192.1M |
| Q4 25 | $54.9M | $228.9M | ||
| Q3 25 | $53.6M | $222.6M | ||
| Q2 25 | $53.8M | $220.2M | ||
| Q1 25 | $52.5M | $223.9M | ||
| Q4 24 | $52.3M | $218.2M | ||
| Q3 24 | $48.9M | $208.1M | ||
| Q2 24 | $52.2M | $201.8M | ||
| Q1 24 | $48.9M | $206.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $11.1M |
| Free Cash FlowOCF − Capex | $2.4M | $10.1M |
| FCF MarginFCF / Revenue | 12.7% | 43.0% |
| Capex IntensityCapex / Revenue | 3.4% | 4.1% |
| Cash ConversionOCF / Net Profit | 1.10× | 3.23× |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $-3.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $11.1M | ||
| Q3 25 | $169.0K | $-275.0K | ||
| Q2 25 | $3.9M | $-23.9M | ||
| Q1 25 | $2.1M | $12.4M | ||
| Q4 24 | $3.2M | $14.8M | ||
| Q3 24 | $2.3M | $-3.2M | ||
| Q2 24 | $4.5M | $-1.0M | ||
| Q1 24 | $1.4M | $11.7M |
| Q4 25 | $2.4M | $10.1M | ||
| Q3 25 | $-83.0K | $-1.3M | ||
| Q2 25 | $3.7M | $-24.4M | ||
| Q1 25 | $1.9M | $12.3M | ||
| Q4 24 | $2.9M | $14.5M | ||
| Q3 24 | $2.3M | $-3.3M | ||
| Q2 24 | $4.5M | $-1.4M | ||
| Q1 24 | $1.3M | $11.7M |
| Q4 25 | 12.7% | 43.0% | ||
| Q3 25 | -0.5% | -6.8% | ||
| Q2 25 | 21.4% | -90.4% | ||
| Q1 25 | 12.2% | 32.2% | ||
| Q4 24 | 18.0% | 46.1% | ||
| Q3 24 | 15.5% | -15.8% | ||
| Q2 24 | 30.1% | -5.6% | ||
| Q1 24 | 9.1% | 28.7% |
| Q4 25 | 3.4% | 4.1% | ||
| Q3 25 | 1.5% | 5.4% | ||
| Q2 25 | 0.8% | 1.8% | ||
| Q1 25 | 1.0% | 0.4% | ||
| Q4 24 | 1.4% | 1.0% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | 0.6% | 0.0% |
| Q4 25 | 1.10× | 3.23× | ||
| Q3 25 | 0.08× | -0.14× | ||
| Q2 25 | 1.75× | -6.24× | ||
| Q1 25 | 1.10× | 2.04× | ||
| Q4 24 | 1.60× | 3.88× | ||
| Q3 24 | 1.57× | -2.22× | ||
| Q2 24 | 2.46× | -0.41× | ||
| Q1 24 | 0.90× | 1.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
GENC
Segment breakdown not available.
